Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://doi.org/10.25358/openscience-8546
Autoren: Fleischer, Maria Isabel
Röhrig, Nadine
Raker, Verena K.
Springer, Juliane
Becker, Detlef
Ritz, Sandra
Bros, Matthias
Stege, Henner
Haist, Maximilian
Grabbe, Stephan
Haub, Jessica
Becker, Christian
Reyda, Sabine
Disse, Jennifer
Schmidt, Talkea
Mahnke, Karsten
Weiler, Hartmut
Ruf, Wolfram
Steinbrik, Kerstin
Titel: Protease- and cell type–specific activation of protease-activated receptor 2 in cutaneous inflammation
Online-Publikationsdatum: 10-Jan-2023
Erscheinungsdatum: 2022
Sprache des Dokuments: Englisch
Zusammenfassung/Abstract: Background: Protease-activated receptor 2 (PAR2) signaling controls skin barrier function and inflammation, but the roles of immune cells and PAR2-activating pro teases in cutaneous diseases are poorly understood. Objective: To dissect PAR2 signaling contributions to skin inflammation with new ge netic and pharmacological tools. Methods/Results: We found markedly increased numbers of PAR2+ infiltrating my eloid cells in skin lesions of allergic contact dermatitis (ACD) patients and in the skin of contact hypersensitivity (CHS) in mice, a murine ACD model for T cell–mediated allergic skin inflammation. Cell type–specific deletion of PAR2 in myeloid immune cells as well as mutation-induced complete PAR2 cleavage insensitivity significantly re duced skin inflammation and hapten-specific Tc1/Th1 cell response. Pharmacological approaches identified individual proteases involved in PAR2 cleavage and demon strated a pivotal role of tissue factor (TF) and coagulation factor Xa (FXa) as upstream activators of PAR2 in both the induction and effector phase of CHS. PAR2 mutant mouse strains with differential cleavage sensitivity for FXa versus skin epithelial cell–expressed proteases furthermore uncovered a time-dependent regulation of CHS development with an important function of FXa-induced PAR2 activation during the late phase of skin inflammation. Conclusions: Myeloid cells and the TF–FXa–PAR2 axis are key mediators and poten tial therapeutic targets in inflammatory skin diseases
DDC-Sachgruppe: 610 Medizin
610 Medical sciences
Veröffentlichende Institution: Johannes Gutenberg-Universität Mainz
Organisationseinheit: FB 04 Medizin
Veröffentlichungsort: Mainz
ROR: https://ror.org/023b0x485
DOI: http://doi.org/10.25358/openscience-8546
Version: Published version
Publikationstyp: Zeitschriftenaufsatz
Nutzungsrechte: CC BY-NC-ND
Informationen zu den Nutzungsrechten: https://creativecommons.org/licenses/by-nc-nd/4.0/
Zeitschrift: Journal of thrombosis and haemostasis
20
12
Seitenzahl oder Artikelnummer: 2823
2836
Verlag: Wiley-Blackwell
Verlagsort: Oxford
Erscheinungsdatum: 2022
ISSN: 1538-7836
DOI der Originalveröffentlichung: 10.1111/jth.15894
Enthalten in den Sammlungen:DFG-491381577-H

Dateien zu dieser Ressource:
  Datei Beschreibung GrößeFormat
Miniaturbild
protease_and_cell_typespecifi-20230110123737986.pdf3.79 MBAdobe PDFÖffnen/Anzeigen